Although the impact of this fusion protein upon dysplastic BE and EAC has not yet been explored, RPS6KB1-VMP1-positive EAC patients displayed poorer survival as compared to not expressing the fusion protein. This evidence concerns the gene VMP1 and Barrett esophagus.